500 RUTHERFORD AVENUE, CHARLESTOWN, MA
Stockholders Elect Clare Kahn, Adam Stone, and Lynne Sullivan as Directors
Annual Report to Security Holders
Director Resignation and Appointment - Ilan Ganot Moves to Class I
Material disclosure
Solid Biosciences Inc. Enters $84 Million Securities Purchase Agreement
Reports Third Quarter 2025 Financial Results and Provides Update on INSPIRE DUCHENNE Clinical Trial Progress and Planned Regulatory Discussions
News
News, Legal Opinion
Q1
FY 2025
Q3
Q2
FY 2024
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Initial Statement of Beneficial Ownership
Prospectus filed pursuant to Rule 424(b)(7)
Correspondence
Submission Upload